These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28035350)

  • 1. Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro.
    Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
    Int J Oncol; 2017 Feb; 50(2):535-544. PubMed ID: 28035350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ.
    Song L; Yang J; Duan P; Xu J; Luo X; Luo F; Zhang Z; Hou T; Liu B; Zhou Q
    Arch Biochem Biophys; 2013 Jul; 535(2):128-35. PubMed ID: 23578572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.
    Rastegar F; Gao JL; Shenaq D; Luo Q; Shi Q; Kim SH; Jiang W; Wagner ER; Huang E; Gao Y; Shen J; Yang K; He BC; Chen L; Zuo GW; Luo J; Luo X; Bi Y; Liu X; Li M; Hu N; Wang L; Luther G; Luu HH; Haydon RC; He TC
    PLoS One; 2010 Dec; 5(12):e14182. PubMed ID: 21152068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis.
    Zhang Z; Zhou Q; Luo F; Zhou R; Xu J; Xiao J; Dai F; Song L
    Hum Cell; 2021 Sep; 34(5):1558-1568. PubMed ID: 34164774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.
    Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
    Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma.
    Wu Z; Min L; Chen D; Hao D; Duan Y; Qiu G; Wang Y
    PLoS One; 2011 Feb; 6(2):e14648. PubMed ID: 21311599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
    Ma J; Huang H; Han Z; Zhu C; Yue B
    Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
    Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
    Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
    Li C; Cai J; Ge F; Wang G
    Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells.
    Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H
    Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.
    Kim M; Jung JY; Choi S; Lee H; Morales LD; Koh JT; Kim SH; Choi YD; Choi C; Slaga TJ; Kim WJ; Kim DJ
    Autophagy; 2017 Jan; 13(1):149-168. PubMed ID: 27754745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of Glucose Transporter Protein-1 by RNA Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in vivo.
    Jian F; Yuan F; Jiong M; Zhu XZ; Yu GR; Lu DD
    Technol Cancer Res Treat; 2015 Apr; 14(2):243-8. PubMed ID: 24502553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
    Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
    Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.
    Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC
    J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a cisplatin‑resistant human osteosarcoma cell line.
    Han T; Zhu X; Wang J; Zhao H; Ma Q; Zhao J; Qiu X; Fan Q
    Oncol Rep; 2014 Sep; 32(3):1133-9. PubMed ID: 25017716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
    He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
    Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
    Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
    Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
    Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
    J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.